Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
Hanmi Pharmaceutical Company Limited · NASH - Nonalcoholic Steatohepatitis
Phase 2
Active, not recruiting
215
2026-06
Evidence dashboardStudies since 2018Updated Jul 31, 2026
EfocipegtrutideClinical Trials.
A source-linked view of every Efocipegtrutide study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
- Total trials
- 3
- Recruiting
- 0
- Completed
- 2
- Terminated
- 0
- Results posted
- 2
- Average enrollment
- 107
- Countries
- 2
- Highest phase
- Phase 2
Largest indexed study
215 participants · NCT04505436 →Developer / research origin
Hanmi Pharmaceutical
Evidence summary
Activity is not efficacy.
Efocipegtrutide appears in 3 indexed studies: 0 recruiting, 2 completed and 2 with registry results posted. The highest registered development stage in this snapshot is Phase 2. These counts measure registry activity; they do not establish that Efocipegtrutide is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Recruiting or active
Completed studies
Finished records
Stopped studies
Withdrawn or terminated
NCT IDStudyPhase / statusEnrollmentUpdated
NCT IDStudyPhase / statusEnrollmentUpdated
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)
Hanmi Pharmaceutical Company Limited · Obesity
Phase 1
Completed
41
2025-02
A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
Hanmi Pharmaceutical Company Limited · NAFLD
Phase 1
Completed
66
2025-01
No studies in this snapshot.
Full study index
Search Efocipegtrutide trials.
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
3 matching studies
Last registry update first
Latest publications
Follow the paper trail.
No PMID-linked publications are present in the indexed registry records for this molecule.
Related pages
Keep researching Efocipegtrutide.
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.